본문 바로가기
메인메뉴
Company
About Qurient
History
Management
Contact Us
Business Philosophy
Business Philosophy
Pipeline
Pipeline
Q702
Q301
TELACEBEC(Q203)
5-Lipoxygenase Inhibitor
Selective CDK7 Inhibitor
IR / PR
Notice
Press Release
Stock Information
Financial
Disclosure
홈페이지로 바로가기
Company
Business Philosophy
Pipeline
IR / PR
Notice
Press Release
Stock Information
Financial
Disclosure
Disclosure
Disclosure
information for download file
Name
Company
Phone
Business e-mail
Comment
Request Download
팝업 닫기
